Side Effects of Taking Wegovy: What Actually Happens and When to Act

Which side effects do most people actually experience on Wegovy?

The side-effect profile of semaglutide is well-documented, having been studied in tens of thousands of participants across the STEP clinical programme. The NHS medicines page for semaglutide sets out the full list, and it is dominated by effects on the digestive system: nausea, vomiting, diarrhoea, constipation, indigestion, reflux and burping. Fatigue, headache and dizziness appear at lower rates. Injection-site reactions (redness, itching or mild swelling where you inject) are reported by some people but are rarely a reason to stop.

Nausea is the one that catches most people off guard. It tends to peak in the first week or two after each new dose, then quietens down. Eating smaller portions, avoiding rich or fatty food and staying well-hydrated all help. Most people find they barely notice it by the time they are settled at their maintenance dose.

A question our prescribers hear most weeks is whether the nausea means the treatment is not working or should be stopped. In most cases, it does not. It reflects semaglutide slowing gastric emptying (the same mechanism that reduces appetite) and the body generally adapts. If it remains severe, the prescriber can pause or slow the titration schedule. You can read a detailed breakdown of what to expect from side effects when taking Wegovy, including practical tips for managing them through each dose stage. This is covered in more detail on our Wegovy side effects overview.

Are there side effects that need urgent medical attention?

Yes, and being clear on these is important. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines highlighted acute pancreatitis as an infrequent but potentially serious risk. The symptom to act on is severe, persistent abdominal pain that may spread to the back, sometimes accompanied by vomiting. If that happens, stop the injection and seek emergency medical care. Do not wait to see whether it settles.

Gallbladder problems (pain in the upper right abdomen, particularly after eating) are also associated with rapid weight loss on any treatment and should be assessed by a doctor promptly. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat) need emergency attention. If heavy vomiting or diarrhoea is causing dehydration (signs include very dark urine, dizziness on standing or barely urinating) that warrants same-day medical review, since dehydration can affect kidney function.

The MHRA Yellow Card scheme exists so that patients can report unexpected or serious side effects directly to the regulator. It is straightforward and takes a few minutes. Reporting helps the MHRA track rare effects in the real-world population and is genuinely useful, not just a formality.

For a broader look at how semaglutide's side-effect profile compares across different formulations, our page on side effects of taking semaglutide covers the shared pharmacology in more depth.

Do side effects differ at higher doses, including the new 7.2mg pen?

Generally yes: gastrointestinal side effects are more likely after a dose increase than during a settled period at the same dose. The licensed semaglutide titration moves up in steps, typically every four weeks, so the pattern tends to repeat in a milder form each time, noticeable for a week or so, then calming. The MHRA approved a dedicated 7.2mg single-dose pen in April 2026, extending the maximum maintenance dose for people with a BMI of 30 or above. The higher the dose, the greater the appetite suppression in trials, but also the higher the rate of GI side effects reported. Your prescriber reviews whether the higher maintenance dose is appropriate for you specifically, it is not automatically the goal.

People sometimes ask whether the side effects of Wegovy when used specifically for weight loss differ from other uses of semaglutide. The medicine is the same; the population differs. Adults taking Wegovy for weight management may notice side effects differently depending on baseline diet, existing conditions and other medicines they take. That individual picture is exactly what the prescriber reviews. You can find more on safety and suitability on our is Wegovy safe page.

How does a clinical assessment shape how you manage side effects?

Wegovy is a prescription-only medicine, which means you cannot legally obtain it without a prescriber's assessment, and that assessment is where side-effect management actually starts. A prescriber who knows your health history can flag in advance which effects you are more likely to experience, whether your other medicines interact with semaglutide's slowing of gastric absorption, and what your plan should be if nausea becomes difficult.

At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber the same day, a real clinician, not automated software. If you have questions or concerns once you have started treatment, our aftercare team is available seven days a week. Side effects that feel manageable with support are very different from side effects managed alone. You can read about the full treatment offering, including aftercare, on our Wegovy treatment page, or explore how semaglutide fits alongside other options on our weight-loss treatments overview. If you are ready to discuss suitability with a prescriber, start your free consultation and our team will review your answers the same day.